Filter Results:
(621)
Show Results For
- All HBS Web
(621)
- People (4)
- News (105)
- Research (425)
- Events (3)
- Multimedia (4)
- Faculty Publications (262)
Show Results For
- All HBS Web
(621)
- People (4)
- News (105)
- Research (425)
- Events (3)
- Multimedia (4)
- Faculty Publications (262)
- Profile
Thomas Grenier
biotech investments. "I showed that it was far more profitable in the United States and that U.S. companies are better at developing new drugs." Thomas will continue to explore health care in his summer internship with... View Details
- Web
Kraft Accelerator
Investing Harvard Business Publishing Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech Harvard Business Publishing Learn how, and why, we got our start HEAR OUR MISSION Before you... View Details
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
infertility: eggs, sperm, and wombs. Sometimes, these components are sold along with IVF treatment—when a couple purchases eggs, for example, they are subsequently used for an IVF procedure—but they are often provided by individual brokers. Then there are the View Details
- 01 Sep 2008
- News
Mara Aspinall
that personalized medicine brings. This is particularly important in fast-moving diseases, where the window for a positive outcome is small. What aspects of their business model do pharmaceutical companies... View Details
- 23 Jul 2001
- Research & Ideas
How Relationships are Building Biotech
on biotech companies in terms of securing resources. And if the top executives had a career background at a pharmaceutical and/or healthcare company—the companies considered... View Details
Keywords: by Martha Lagace & Mallory Stark
- 01 Sep 2012
- News
A Silent Workplace Crisis
pharmaceuticals, the gap between the medical and the mental health systems, and the time required to find community resources and quality home care. My previous experience as a pharmaceutical executive and management consultant seemed... View Details
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
entrepreneur who has had a successful career in business, finance, yachting, and philanthropy. He is the former CEO of Serono SA (formerly known Ares-Serono), a family-controlled global pharmaceuticals and biotechnology leader whose roots... View Details
- 01 Sep 2015
- Blog Post
Building a Startup at HBS
prototype which we showcased at HBS and tested out in the NICU to observe its efficacy and nurse uptake. While we each embarked on different paths after the end of first year– from launching a new healthcare venture in Africa, to working at large View Details
- 20 May 2013
- Op-Ed
Making America an Industrial Powerhouse Again
talent pool in the US biomedical field that is second to none. And the only way to get that talent is for companies-both domestic and foreign-to do their R&D here. That's why pharmaceutical and biotechnology View Details
- 15 Feb 2012
- Op-Ed
Occupy Wall Street Protestors Have a Point
unaffordable (which the pharmaceutical company Cipla did with HIV/AIDS drugs in Africa), and that brought housing to urban poor (one of building materials maker CEMEX's accomplishments in Mexico). Based on... View Details
- Profile
Rocio Parra
Why was getting a business education important to you? As a consultant, I had the opportunity to work in a variety of industries from pharmaceuticals and medical devices to government and consumer packaged goods. Through these... View Details
Keywords: Retail
- 24 Sep 2020
- News
The Race for a Vaccine
headlines, the vaccine sector was a pretty sleepy space. Interest in vaccine development and production had been on the decline for decades. In the 1960s—the triumphant years after Jonas Salk discovered the first polio vaccine—there were 26 View Details
- 01 Mar 2012
- News
Capitalism’s New Agenda
remedies that would make things worse, but were against any intervention by business because business had no legitimacy—“it’s above my pay grade.” Still others thought that business should use its influence to activate government. A final group thought View Details
- 28 Mar 2023
- Blog Post
Novo Nordisk
learned details of how Novo Nordisk manufactures within its 1,200,000 square meter facility high-quality active pharmaceutical ingredients (APIs) that tackle not only diabetes but also hemophilia, growth disorders, and obesity. At their... View Details
- Web
Kraft Accelerator
School, Founder, Multiple Myeloma Research Foundation Kathy Giusti is a thinker, motivator, and, above all, a doer. Following her cancer diagnosis, the former pharmaceutical executive channeled her frustration over limited treatment... View Details
- 01 Mar 2003
- News
Naina Lal Kidwai
to the global automobile industry. Biotechnology and pharmaceutical firms are emerging as international players. There are also opportunities in infrastructure investment, such as telecom, ports, roads, and airports. Please comment on... View Details
- 10 Jun 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Cofounders, Anne-Marie Schoonbeek and Heleen van Poecke
that perspective to the next level,” she shared. Schoonbeek was also eager to gain more experience as an operator at a startup company to supplement her experience as a consultant working with large businesses. Specifically, she was drawn... View Details
- 18 Aug 2017
- Op-Ed
Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump
companies like Frazier and Merck got from the President. Their companies have products dependent on government approvals and major regulatory issues before Congress and the administration. Given these... View Details
Keywords: by Bill George
- 30 Apr 2001
- Research & Ideas
Entering the Age of Alliances
competencies of each partner and create two-way value is evidenced by, among others, the collaboration between The College Fund (UNCF) and Merck. UNCF, the largest and oldest minority educational assistance organization in the United States, and Merck, a leading global... View Details
Keywords: by James Austin
- 15 Sep 2009
- First Look
First Look: September 15
research. Download the paper from SSRN ($5): http://papers.nber.org/papers/w15319 PublicationsSuperCorp: How Vanguard Companies Create Innovation, Profits, Growth, and Social Good Author:Rosabeth M. Kanter Publication:New York: Crown,... View Details
Keywords: Martha Lagace